首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Bjc reports

缩写:BJC REP

ISSN:N/A

e-ISSN:2731-9377

IF/分区:3.8/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引235条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Karoliina Aro,Mikko Loukovaara,Ralf Bützow et al. Karoliina Aro et al.
Background: Emerging HER2-targeted therapies provide new treatment options for patients with HER2-expressing tumors. This study investigates the prevalence of HER2 amplification and HER2 low expression across a well-chara...
Ross D Dolan,Kathryn Pennel,Joshua Thompson et al. Ross D Dolan et al.
Background: In cancer cachexia the relationship between the tumour, its environment and the systemic inflammatory response is not clear. This study aims to examine this relationship in greater detail. ...
Ryunosuke Oyama,Akira Nabeshima,Makoto Endo et al. Ryunosuke Oyama et al.
Background: Osteosarcoma is the most common malignant bone tumour with limited treatment options and poor outcomes in advanced metastatic cases. Current immunotherapies show limited efficacy, highlighting the need for nov...
Cian Campion,Linda Robertson,Ian Stansfield et al. Cian Campion et al.
Single-use plastics (SUPs) are used widely in cancer research laboratories. They are cheap, durable, and lightweight, and until now have been considered disposable items. This, however, contributes significantly to unsustainable waste produ...
Amaury Herbet,Marie Hautière,Frédéric Jean-Alphonse et al. Amaury Herbet et al.
Background: Endothelin 1 receptors are one of the drivers of tumor progression in many cancers. Inhibition of their signaling pathways with antagonist drugs has been the subject of numerous clinical trials, but the result...
Takeshi Terashima,Kouki Nio,Naohiko Koshikawa et al. Takeshi Terashima et al.
Background: The identification of effective diagnostic and prognostic biomarkers is critical to improving the outcomes of patients with pancreatic ductal adenocarcinoma (PDAC). We explored the potential of serum levels of...
Aurora Norman,Mahesh Seetharam,Jacob Allred et al. Aurora Norman et al.
Background: Based on preclinical data showing addition of CDK4/6 inhibitors to gemcitabine was synergistic, ribociclib was evaluated in combination with gemcitabine to determine the maximum tolerated dose (MTD) and dose l...
Nicole L Brown,Susan Pritchard,Elaine F Harkness et al. Nicole L Brown et al.
Background: Atypical ductal hyperplasia (ADH) and lobular neoplasia (LN) increase subsequent breast cancer (BC) risk. However, optimal surveillance and risk reduction regimes remain uncertain. We report management and out...
Helena Taflin,Elisabeth Odin,Göran Carlsson et al. Helena Taflin et al.
Background: 5-Fluorouracil (5-FU) is a cornerstone in treatment of colorectal cancer (CRC) and is usually combined with leucovorin (LV) to enhance the antitumour effect by increase thymidylate synthase (TS) inhibition, th...
Yuri Sakimoto,Kohei Kumegawa,Shimpei Matsui et al. Yuri Sakimoto et al.
Background: Peritoneal metastasis, a major complication of colorectal cancer (CRC), often leads to poor quality of life and unfavorable outcomes. Despite numerous studies characterizing its biological features in CRC, int...